CPT® Code 80372

The CPT® Code 80372 refers to a laboratory test specifically designed to measure the presence and concentration of tapentadol in biological samples such as urine, serum, or plasma. Tapentadol, which is marketed under the brand name Nucynta, is classified as a central acting opioid analgesic. Its mechanism of action involves agonism of the opioid receptors, which helps to alleviate pain by inhibiting the reuptake of norepinephrine, thereby enhancing analgesic effects. This medication is primarily utilized for the management of moderate to severe acute pain, serving as an alternative to traditional opiate medications. Additionally, tapentadol may be prescribed in an extended-release formulation for the treatment of diabetic peripheral neuropathy, a condition characterized by nerve damage due to diabetes. The testing process for tapentadol involves obtaining a blood sample through a procedure known as venipuncture, which is separately reportable, or collecting urine via random voiding or catheterization. The analysis of urine, serum, and plasma samples is conducted using a sophisticated technique known as quantitative liquid chromatography-tandem mass spectrometry, which allows for precise measurement of the drug's concentration in the samples tested.